| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-08 |